HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Left ventricular myocardial performance index in closely-related relatives of patients with dilated cardiomyopathy.

Abstract
In this study, the left ventricular dimensions, systolic function, and left ventricular myocardial performance index in the first-degree relatives of the children with dilated cardiomyopathy (n=19), 30.0+/-17.6 years to normal age- and sex-matched controls (n=25), 27.4+/-17.7 years. The percentage ratio of the measured left ventricular end-diastolic dimension to the predicted left ventricular end-diastolic dimension (109+/-9.6 vs 105+/-11.8), left ventricular shortening fraction (34.5+/-6.6 vs 37.2+/-7%), and left ventricular ejection fraction (63.2+/-9.2 vs 66.5+/-8.1%) were not significantly different in the first-degree relatives and controls, respectively. However, the left ventricular myocardial performance index was significantly greater in the first-degree relatives than in controls (0.40+/-0.11 vs 0.31+/-0.03, p=0.01). In conclusion, the left ventricular myocardial performance index may be useful in early detect familial dilated cardiomyopathy in asymptomatic first-degree relatives of children with dilated cardiomyopathy.
AuthorsAnant Khositseth, Prapat Ausayapao
JournalInternational journal of cardiology (Int J Cardiol) Vol. 124 Issue 3 Pg. 375-7 (Mar 14 2008) ISSN: 1874-1754 [Electronic] Netherlands
PMID17363090 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Cardiomyopathy, Dilated (diagnostic imaging, genetics, physiopathology)
  • Echocardiography
  • Family
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Ventricular Function, Left (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: